Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1908 1
1950 2
1951 1
1953 1
1954 2
1956 1
1958 1
1960 2
1961 2
1962 2
1964 1
1966 4
1967 1
1968 3
1969 1
1970 3
1971 3
1972 7
1973 3
1974 3
1975 11
1976 9
1977 13
1978 9
1979 6
1980 8
1981 6
1982 7
1983 7
1984 4
1985 7
1986 7
1987 7
1988 7
1989 11
1990 12
1991 8
1992 12
1993 12
1994 17
1995 18
1996 15
1997 13
1998 15
1999 15
2000 16
2001 25
2002 19
2003 20
2004 25
2005 24
2006 38
2007 41
2008 41
2009 53
2010 44
2011 46
2012 41
2013 42
2014 27
2015 37
2016 57
2017 53
2018 49
2019 51
2020 57
2021 64
2022 68
2023 90
2024 85
2025 60

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,366 results

Results by year

Filters applied: . Clear all
Page 1
A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings.
Véniant MM, Lu SC, Atangan L, Komorowski R, Stanislaus S, Cheng Y, Wu B, Falsey JR, Hager T, Thomas VA, Ambhaikar M, Sharpsten L, Zhu Y, Kurra V, Jeswani R, Oberoi RK, Parnes JR, Honarpour N, Neutel J, Strande JL. Véniant MM, et al. Among authors: thomas va. Nat Metab. 2024 Feb;6(2):290-303. doi: 10.1038/s42255-023-00966-w. Epub 2024 Feb 5. Nat Metab. 2024. PMID: 38316982 Free PMC article. Clinical Trial.
Sebaceous carcinoma: evidence-based clinical practice guidelines.
Owen JL, Kibbi N, Worley B, Kelm RC, Wang JV, Barker CA, Behshad R, Bichakjian CK, Bolotin D, Bordeaux JS, Bradshaw SH, Cartee TV, Chandra S, Cho NL, Choi JN, Council ML, Demirci H, Eisen DB, Esmaeli B, Golda N, Huang CC, Ibrahim SF, Jiang SB, Kim J, Kuzel TM, Lai SY, Lawrence N, Lee EH, Leitenberger JJ, Maher IA, Mann MW, Minkis K, Mittal BB, Nehal KS, Neuhaus IM, Ozog DM, Petersen B, Rotemberg V, Samant S, Samie FH, Servaes S, Shields CL, Shin TM, Sobanko JF, Somani AK, Stebbins WG, Thomas JR, Thomas VD, Tse DT, Waldman AH, Wong MK, Xu YG, Yu SS, Zeitouni NC, Ramsay T, Reynolds KA, Poon E, Alam M. Owen JL, et al. Among authors: thomas vd. Lancet Oncol. 2019 Dec;20(12):e699-e714. doi: 10.1016/S1470-2045(19)30673-4. Lancet Oncol. 2019. PMID: 31797796 Review.
Basal Cell Skin Cancer, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Schmults CD, Blitzblau R, Aasi SZ, Alam M, Amini A, Bibee K, Bordeaux J, Chen PL, Contreras CM, DiMaio D, Donigan JM, Farma JM, Ghosh K, Harms K, Ho AL, Lukens JN, Mark L, Medina T, Nehal KS, Nghiem P, Olino K, Park S, Patel T, Puzanov I, Rich J, Sekulic A, Shaha AR, Srivastava D, Thomas V, Tomblinson C, Venkat P, Xu YG, Yu S, Yusuf M, McCullough B, Espinosa S. Schmults CD, et al. Among authors: thomas v. J Natl Compr Canc Netw. 2023 Nov;21(11):1181-1203. doi: 10.6004/jnccn.2023.0056. J Natl Compr Canc Netw. 2023. PMID: 37935106
NCCN Guidelines® Insights: Merkel Cell Carcinoma, Version 1.2024.
Schmults CD, Blitzblau R, Aasi SZ, Alam M, Amini A, Bibee K, Bolotin D, Bordeaux J, Chen PL, Contreras CM, DiMaio D, Donigan JM, Farma JM, Ghosh K, Harms K, Ho AL, Lukens JN, Manber S, Mark L, Medina T, Nehal KS, Nghiem P, Olino K, Park S, Patel T, Puzanov I, Rich J, Sekulic A, Shaha AR, Srivastava D, Thomas V, Tomblinson C, Venkat P, Xu YG, Yu S, Yusuf M, McCullough B, Espinosa S. Schmults CD, et al. Among authors: thomas v. J Natl Compr Canc Netw. 2024 Jan;22(1D):e240002. doi: 10.6004/jnccn.2024.0002. J Natl Compr Canc Netw. 2024. PMID: 38244274
Reply by Authors.
Gebrael G, Sayegh N, Tripathi N, Goel D, McFarland T, Ebrahimi H, Nordblad B, Chigarira B, Thomas VM, Sahu KK, Li H, Chehrazi-Raffle A, Kohli M, Agarwal N, Swami U, Maughan BL. Gebrael G, et al. Among authors: thomas vm. Urol Pract. 2023 Oct 30:101097UPJ000000000000047102. doi: 10.1097/UPJ.0000000000000471.02. Online ahead of print. Urol Pract. 2023. PMID: 37903752 No abstract available.
Foreword.
Kanstrup N, Thomas VG, Fox AD. Kanstrup N, et al. Among authors: thomas vg. Ambio. 2019 Sep;48(9):923-924. doi: 10.1007/s13280-019-01220-y. Ambio. 2019. PMID: 31286457 Free PMC article. No abstract available.
GIPR-Ab/GLP-1 peptide-antibody conjugate requires brain GIPR and GLP-1R for additive weight loss in obese mice.
Liu CM, Killion EA, Hammoud R, Lu SC, Komorowski R, Liu T, Kanke M, Thomas VA, Cook K, Sivits GN Jr, Ben AB, Atangan LI, Hussien R, Tang A, Shkumatov A, Li CM, Drucker DJ, Véniant MM. Liu CM, et al. Among authors: thomas va. Nat Metab. 2025 Jun;7(6):1266-1281. doi: 10.1038/s42255-025-01295-w. Epub 2025 Apr 29. Nat Metab. 2025. PMID: 40301582 Free PMC article.
Take my breath away.
Thomas VC, Fey PD. Thomas VC, et al. Elife. 2017 Apr 4;6:e25739. doi: 10.7554/eLife.25739. Elife. 2017. PMID: 28374675 Free PMC article.
1,366 results